Thymic Stromal Lymphopoietin Induction Suppresses Lung Cancer Development

SIMPLE SUMMARY: The recurrence rate for lung cancer is high after the removal of the primary tumor. Herein, we demonstrate the potential of immunotherapy against lung cancer by examining the impact of Thymic Stromal Lymphopoietin (TSLP) cytokine induction on early lung cancer development. TSLP induc...

Descripción completa

Detalles Bibliográficos
Autores principales: Guennoun, Ranya, Hojanazarova, Jennet, Trerice, Kathryn E., Azin, Marjan, McGoldrick, Matthew T., Schiferle, Erik B., Stover, Michael P., Demehri, Shadmehr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104311/
https://www.ncbi.nlm.nih.gov/pubmed/35565302
http://dx.doi.org/10.3390/cancers14092173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104311/
https://www.ncbi.nlm.nih.gov/pubmed/35565302
http://dx.doi.org/10.3390/cancers14092173

Ejemplares similares